Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting Type 2 diabetes and certain addiction disorders. Semaglutide, the active ...

Popular drugs for diabetes and weight loss could have an unexpected side ... Some common GLP-1 drugs include Ozempic and Wegovy, which contain semaglutide as the active ingredient, and Mounjaro ...

The best use of this class of ... say they’re comfortable prescribing semaglutide long-term for weight loss for a patient eligible for the medication. With close monitoring by a health care ...

while around a third of patients treated with 7.2mg achieved more than 25% weight loss. "Results from STEP UP further strengthen the clinical profile of semaglutide for the treatment of obesity ...

Criminals are targeting pharmacies and stealing weight-loss medication in a country with ... Novo Nordisk’s Brazilian patent for semaglutide, the active ingredient in Ozempic and Wegovy, expires ...